These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 4036118)
21. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038 [TBL] [Abstract][Full Text] [Related]
22. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. van Milligen de Wit AW; van Deventer SJ; Tytgat GN Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416 [TBL] [Abstract][Full Text] [Related]
24. Association of primary sclerosing cholangitis with HLA-B8. Chapman RW; Varghese Z; Gaul R; Patel G; Kokinon N; Sherlock S Gut; 1983 Jan; 24(1):38-41. PubMed ID: 6600227 [TBL] [Abstract][Full Text] [Related]
25. Sclerosing cholangitis associated with chronic cryptosporidiosis in a child with a congenital immunodeficiency disorder. Davis JJ; Heyman MB; Ferrell L; Kerner J; Kerlan R; Thaler MM Am J Gastroenterol; 1987 Nov; 82(11):1196-202. PubMed ID: 3674002 [TBL] [Abstract][Full Text] [Related]
26. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Mehal WZ; Lo YM; Wordsworth BP; Neuberger JM; Hubscher SC; Fleming KA; Chapman RW Gastroenterology; 1994 Jan; 106(1):160-7. PubMed ID: 8276178 [TBL] [Abstract][Full Text] [Related]